RXRA and urinary bladder cancer: To establish a causal role of RXRA hot-spot mutations in hyper-activation of PPAR singling, we used retroviral transduction to introduce wild-type or mutant RXRA into two bladder cancer cell lines, JMSU-1 and 575A.